Stay updated with breaking news from Jeff Chilton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration has declined to respond to a Citizen Petition by North American Reishi Ltd (“Nammex”) on the labeling and sale of food and supplements containing fungal ingredients, citing “competing agency priorities”.
Mushroom ingredient supplier Nammex had asked FDA to clarify labeling requirements for fungi ingredients. FDA declined to take action.
A Nammex-commissioned survey of 10,000 people in the US confirms the population can easily identify a mushroom. The task may seem simple, but the act supports a greater argument by Nammex, the supplier of functional mushroom extracts, that mycelium-containing products are not mushrooms.
The Natural Products Association asks FDA to clarify mushroom labeling.
The Natural Products Association is seeking greater clarity about how fungal dietary supplements are labeled.